179 related articles for article (PubMed ID: 34247471)
1. The feasibility and efficacy of short-term visual-motor training in pediatric posterior fossa tumor survivors.
Kasatkin V; Deviaterikova A; Shurupova M; Karelin A
Eur J Phys Rehabil Med; 2022 Feb; 58(1):51-59. PubMed ID: 34247471
[TBL] [Abstract][Full Text] [Related]
2. Motor Functioning and Intelligence Quotient in Paediatric Survivors of a Fossa Posterior Tumor Following a Multidisciplinary Rehabilitation Program.
Decock M; De Wilde R; Van der Looven R; Vander Linden C
Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742337
[TBL] [Abstract][Full Text] [Related]
3. Effects of cognitive-motor intervention for pediatric posterior fossa tumor survivors: results of a pilot study.
Kasatkin VN; Romanova EN; Glebova EV; Deviaterikova AA; Tolchennikova VV; Sharapkova AA; Manukyan PA; Karpova NM; Sarkisyan RA; Karelin AF
J Neurooncol; 2024 May; 168(1):57-67. PubMed ID: 38489149
[TBL] [Abstract][Full Text] [Related]
4. Cerebral white matter fractional anisotropy and tract volume as measured by MR imaging are associated with impaired cognitive and motor function in pediatric posterior fossa tumor survivors.
Rueckriegel SM; Bruhn H; Thomale UW; Hernáiz Driever P
Pediatr Blood Cancer; 2015 Jul; 62(7):1252-8. PubMed ID: 25850573
[TBL] [Abstract][Full Text] [Related]
5. DTI fiber tractography of cerebro-cerebellar pathways and clinical evaluation of ataxia in childhood posterior fossa tumor survivors.
Oh ME; Driever PH; Khajuria RK; Rueckriegel SM; Koustenis E; Bruhn H; Thomale UW
J Neurooncol; 2017 Jan; 131(2):267-276. PubMed ID: 27785688
[TBL] [Abstract][Full Text] [Related]
6. Long-term neuromotor speech deficits in survivors of childhood posterior fossa tumors: effects of tumor type, radiation, age at diagnosis, and survival years.
Huber JF; Bradley K; Spiegler B; Dennis M
J Child Neurol; 2007 Jul; 22(7):848-54. PubMed ID: 17715277
[TBL] [Abstract][Full Text] [Related]
7. Comparison of neuropsychological functioning in pediatric posterior fossa tumor survivors: Medulloblastoma, low-grade astrocytoma, and healthy controls.
Levitch CF; Holland AA; Bledsoe J; Kim SY; Barnett M; Ramjan S; Sands SA
Pediatr Blood Cancer; 2022 Feb; 69(2):e29491. PubMed ID: 34842359
[TBL] [Abstract][Full Text] [Related]
8. Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for medulloblastoma on a multi-institutional, prospective study.
Schreiber JE; Palmer SL; Conklin HM; Mabbott DJ; Swain MA; Bonner MJ; Chapieski ML; Huang L; Zhang H; Gajjar A
Neuro Oncol; 2017 Nov; 19(12):1673-1682. PubMed ID: 29016818
[TBL] [Abstract][Full Text] [Related]
9. Possible association between the integrity of cerebellar pathways and neurocognitive performance in children with posterior fossa tumors.
Liguoro I; Passone E; Zilli T; Maieron M; De Colle MC; Skrap M; Dolcemascolo V; Sommariva G; Cogo P; Tomasino B
Pediatr Blood Cancer; 2020 Sep; 67(9):e28538. PubMed ID: 32652734
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychological Profile in Children with Posterior Fossa Tumors with or Without Postoperative Cerebellar Mutism Syndrome (CMS).
Cámara S; Fournier MC; Cordero P; Melero J; Robles F; Esteso B; Vara MT; Rodríguez S; Lassaletta Á; Budke M
Cerebellum; 2020 Feb; 19(1):78-88. PubMed ID: 31832994
[TBL] [Abstract][Full Text] [Related]
11. Physical functioning in pediatric survivors of childhood posterior fossa brain tumors.
Piscione PJ; Bouffet E; Mabbott DJ; Shams I; Kulkarni AV
Neuro Oncol; 2014 Jan; 16(1):147-55. PubMed ID: 24305707
[TBL] [Abstract][Full Text] [Related]
12. Oculomotor Impairments in Children After Posterior Fossa Tumors Treatment.
Shurupova MA; Latanov AV
Cerebellum; 2024 Apr; 23(2):444-454. PubMed ID: 37000368
[TBL] [Abstract][Full Text] [Related]
13. Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma.
Palmer SL; Hassall T; Evankovich K; Mabbott DJ; Bonner M; Deluca C; Cohn R; Fisher MJ; Morris EB; Broniscer A; Gajjar A
Neuro Oncol; 2010 Dec; 12(12):1311-7. PubMed ID: 20713408
[TBL] [Abstract][Full Text] [Related]
14. Persistent cognitive dysfunction secondary to cerebellar injury in patients treated for posterior fossa tumors in childhood.
Rønning C; Sundet K; Due-Tønnessen B; Lundar T; Helseth E
Pediatr Neurosurg; 2005; 41(1):15-21. PubMed ID: 15886508
[TBL] [Abstract][Full Text] [Related]
15. Morphological brain lesions of pediatric cerebellar tumor survivors correlate with inferior neurocognitive function but do not affect health-related quality of life.
Khajuria RK; Blankenburg F; Wuithschick I; Rueckriegel S; Thomale UW; Mansour M; Driever PH
Childs Nerv Syst; 2015 Apr; 31(4):569-80. PubMed ID: 25686892
[TBL] [Abstract][Full Text] [Related]
16. Cognitive consequences of the treatment of medulloblastoma among children.
Saury JM; Emanuelson I
Pediatr Neurol; 2011 Jan; 44(1):21-30. PubMed ID: 21147383
[TBL] [Abstract][Full Text] [Related]
17. Eurythmy therapy in the aftercare of pediatric posterior fossa tumour survivors--a pilot study.
Kanitz JL; Pretzer K; Calaminus G; Wiener A; Längler A; Henze G; Driever PH; Seifert G
Complement Ther Med; 2013 Apr; 21 Suppl 1():S3-9. PubMed ID: 23578915
[TBL] [Abstract][Full Text] [Related]
18. Critical risk factors for intellectual impairment in children with posterior fossa tumors: the role of cerebellar damage.
Grill J; Viguier D; Kieffer V; Bulteau C; Sainte-Rose C; Hartmann O; Kalifa C; Dellatolas G
J Neurosurg; 2004 Nov; 101(2 Suppl):152-8. PubMed ID: 15835102
[TBL] [Abstract][Full Text] [Related]
19. Impact of a pediatric posterior fossa tumor and its treatments on motor procedural learning.
Baudou E; Danna J; Tallet J; Pollidoro L; Tensaouti F; Bertozzi AI; Pariente J; Courbieres N; Dufour C; Grill J; Chaix Y; Laprie A
Eur J Paediatr Neurol; 2023 May; 44():37-45. PubMed ID: 37060708
[TBL] [Abstract][Full Text] [Related]
20. Loss of fine motor function correlates with ataxia and decline of cognition in cerebellar tumor survivors.
Rueckriegel SM; Blankenburg F; Henze G; Baqué H; Driever PH
Pediatr Blood Cancer; 2009 Sep; 53(3):424-31. PubMed ID: 19484752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
